5/10
04:58 pm
lctx
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/9
04:44 pm
lctx
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/9
04:01 pm
lctx
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Low
Report
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
5/6
08:00 am
lctx
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
High
Report
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
5/2
08:11 am
lctx
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 [Yahoo! Finance]
5/2
08:00 am
lctx
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
Medium
Report
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
4/30
08:05 am
lctx
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) [Yahoo! Finance]
Low
Report
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) [Yahoo! Finance]
4/30
08:00 am
lctx
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)
Medium
Report
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)
4/29
04:47 pm
lctx
Lineage Announces Changes to Board of Directors [Yahoo! Finance]
Low
Report
Lineage Announces Changes to Board of Directors [Yahoo! Finance]
4/29
04:30 pm
lctx
Lineage Announces Changes to Board of Directors
Low
Report
Lineage Announces Changes to Board of Directors
4/1
08:19 am
lctx
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development [Yahoo! Finance]
Low
Report
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development [Yahoo! Finance]
4/1
08:00 am
lctx
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
Low
Report
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development
3/28
01:35 pm
lctx
These 2 ‘Strong Buy' Penny Stocks Could Go Boom, Say Analysts [Yahoo! Finance]
Low
Report
These 2 ‘Strong Buy' Penny Stocks Could Go Boom, Say Analysts [Yahoo! Finance]
3/18
08:17 am
lctx
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium [Yahoo! Finance]
High
Report
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium [Yahoo! Finance]
3/18
08:00 am
lctx
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
Medium
Report
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
3/13
08:00 am
lctx
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Medium
Report
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
3/11
08:16 am
lctx
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting [Yahoo! Finance]
Medium
Report
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting [Yahoo! Finance]
3/11
08:00 am
lctx
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
Medium
Report
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
3/8
04:25 pm
lctx
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
10:47 pm
lctx
Lineage Cell Therapeutics Inc. Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]
High
Report
Lineage Cell Therapeutics Inc. Reports Q4 and Full Year 2023 Financial Results [Yahoo! Finance]
3/7
04:23 pm
lctx
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/7
04:01 pm
lctx
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
High
Report
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2/29
08:21 am
lctx
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024 [Yahoo! Finance]
Low
Report
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024 [Yahoo! Finance]
2/29
08:00 am
lctx
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024
Low
Report
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024